Wells Fargo & Company »

Avalo Therapeutics Ord shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $10 1 10.00
2024-06-30 $12 1 12.00
2024-03-31 $174 8 21.83
2023-12-31 $72 8 9.00